Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer [Phase 2]
Phase 2 study of ramucirumab in gastric and GEJ cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Comparison of Open Laparoscopic and Robotic Surgery in Gastric Cancer Resection. [NA]
This clinical trial compares open laparoscopic versus robotic surgery for gastric cancer resection. The current status of the trial is unkno…
-
CLINICAL_TRIALS research · 2018-02-26Clinical Trial Update: Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer [Phase 1, Phase 2]
Exploratory Phase 1/2 clinical study evaluating apatinib plus SHR-1210 in advanced gastric cancer or hepatocellular carcinoma; status is unk…
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating irinotecan and docetaxel in metastatic or unresectable gastric or gastroesophageal junction adenocarcinoma has comp…
-
CLINICAL_TRIALS trial_result · 2018-02-14Clinical Trial Update: A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer [Phase 3]
Phase 3 trial evaluating pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic gastroesophageal junction or gastric cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells [Phase 2]
Phase 2 clinical trial update investigating HIPEC plus Apatinib and S-1 conversion therapy for gastric cancer with positive exfoliative canc…
-
CLINICAL_TRIALS research · 2018-02-09Clinical Trial Update: Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer [Phase 1, Phase 2]
A clinical trial evaluating hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer in Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer [Phase 2, Phase 3]
A randomized controlled trial in gastric cancer with peritoneal carcinomatosis was terminated; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer [Phase 2]
Phase 2 clinical trial update for dendritic cell-based immunotherapy in gastric cancer is reported with unknown status.
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total Gastrectomy [Phase 3]
Phase 3 trial comparing Roux-en-Y vs Roux-en-Y+ pouch after total gastrectomy for gastric cancer; current status and results not provided.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis [Phase 2]
Phase II study evaluating neoadjuvant XELOX plus lapatinib in HER2-positive gastric cancer with liver metastasis has been completed.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma [Phase 2]
Phase 2 trial investigating nimotuzumab plus irinotecan as second-line therapy for recurrent or metastatic gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor [Phase 2, Phase 3]
A clinical trial comparing chemotherapy alone to surgery plus chemotherapy for distal gastric cancer with one non-curable factor; phases 2 a…
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection [Phase 2]
Phase 2 clinical trial evaluating adjuvant IMRT with concurrent raltitrexed chemotherapy after D0/D1 gastric cancer resection.
-
CLINICAL_TRIALS trial_result · 2017-12-29Clinical Trial Update: Study of Anlotinib in Patients With Gastric Cancer(ALTER0503) [Phase 2, Phase 3]
Clinical trial update for Anlotinib in gastric cancer (ALTER0503) spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery [Phase 2]
Phase 2 pilot trial of CRLX101 for advanced/metastatic stomach, gastroesophageal junction, or esophageal cancers that are unresectable; tria…
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Engagement of Patients With Advanced Cancer [NA]
Clinical trial update noting engagement of patients with advanced cancer; status completed and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating pralatrexate and oxaliplatin in unresectable or metastatic esophageal, stomach, or gastroesophageal juncti…
-
CLINICAL_TRIALS research · 2017-12-11Clinical Trial Update: Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors [NA]
A clinical trial update concerning the proximal resection margin length for Siewert II/III esophagogastric junction tumors; the current stat…
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: Povidone-iodine and the Normal Saline Cleaning the Incision for the SSIs [NA]
A clinical trial update comparing povidone-iodine versus normal saline cleaning of surgical incisions to prevent surgical site infections in…
-
CLINICAL_TRIALS research · 2017-12-11Clinical Trial Update: Effect of Obesity on Surgical Outcomes and Survival for Gastric Cancer [NA]
This clinical trial update examines how obesity may influence surgical outcomes and survival in gastric cancer. The current status of the tr…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer [Phase 2]
This Phase 2 trial evaluated sequential administration of irinotecan (CPT-11) and mitomycin C in patients with advanced esophageal or gastri…
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update across multiple cancer types including ovarian, non-small cell lung, prostate, colorectal, gastric/esophageal,…
-
FDA approval · 2017-12-01FDA Approved: OGIVRI — Original Application (Biocon Biologics Inc.)
The FDA approved OGIVRI (trastuzumab-dkst) from Biocon Biologics as a biosimilar to trastuzumab through Biocon's Original Application. It is…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Safety, Feasibility and Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Pilot Study [NA]
This completed pilot trial evaluated the safety, feasibility, and potential effects of an individualized physical activity intervention for …